Form 10-Q MidCap Financial Investm For: Mar 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260506/AO22DQ2EZ22R8ZZZ2H2H2ZYNES88EZ22Z282
Filed on: May 6, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
- Tunkillia Pre-Feasibility Study Begins
- Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
